Anu Laboratories IPO vs Bafna Pharmaceuticals IPO

Comparision between Anu Laboratories IPO and Bafna Pharmaceuticals IPO.

IPO Details

Anu Laboratories IPO is a Mainline Fixed Price Issue IPO proposed to list at BSE while Bafna Pharmaceuticals IPO is a Mainline Fixed Price Issue proposed to list at BSE.

	Anu Laboratories IPO	Bafna Pharmaceuticals IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Fixed Price Issue
Listing At	BSE	BSE
Lead Managers	Almondz Global Securities Limited	Keynote Financial Services Ltd Ashika Capital Ltd
Registrar	Kfin Technologies Limited	Cameo Corporate Services Limited
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Anu Laboratories IPO is up to ₹80.22 Cr whereas the issue size of the Bafna Pharmaceuticals IPO is up to ₹25.60 Cr. The final issue price of Anu Laboratories IPO is ₹210.00 per share and of Bafna Pharmaceuticals IPO is ₹40.00 per share.

	Anu Laboratories IPO	Bafna Pharmaceuticals IPO
Face Value	₹10 per share	₹10 per share
Issue Price (Lower)	₹200.00 per share
Issue Price (Upper)	₹210.00 per share
Issue Price (Final)	₹210.00 per share	₹40.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size	30 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total	38,20,000 shares	64,00,000 shares
Issue Size Total (Amount)	up to ₹80.22 Cr	up to ₹25.60 Cr

IPO Timetable

Anu Laboratories IPO opens on May 12, 2008, while Bafna Pharmaceuticals IPO opens on May 27, 2008. The closing date of Anu Laboratories IPO and Bafna Pharmaceuticals IPO is May 15, 2008, and May 30, 2008, respectively.

	Anu Laboratories IPO	Bafna Pharmaceuticals IPO
Anchor Bid Date
Issue Open	May 12, 2008	May 27, 2008
Issue Close	May 15, 2008	May 30, 2008
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials

Anu Laboratories IPO P/E ratio is , as compared to Bafna Pharmaceuticals IPO P/E ratio of .

Anu Laboratories IPO

Bafna Pharmaceuticals IPO

Financial

Particulars	For the year/period ended (Rs. in lakhs)
	31-Mar-07	31-Mar-06	31-Mar-05	31-Mar-04
Total Income	12,129.52	9,533.93	6,722.41	2,810.08
Profit After Tax (PAT)	1,359.15	571.09	209.07	54.00

Particulars	For the year/period ended (Rs. in lacs)
	30-Jun-07	31-Mar-07	31-Mar-06	31-Mar-05	31-Mar-04
Total Income	432.02	3861.96	2136.47	2662.65	1521.33
Profit After Tax (PAT)	49.70	104.23	92.27	89.81	44.51

Promoter Shareholding (Pre-Issue)

71.07%

Promoter Shareholding (Post-Issue)

42.6%

P/E Ratio

Market Cap

ROE

ROCE

Debt/Equity

EPS

RoNW

10.65%%

Shares Offered

In the Anu Laboratories IPO retail investors (RII) are offered while in Bafna Pharmaceuticals IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Anu Laboratories IPO and in Bafna Pharmaceuticals IPO.

	Anu Laboratories IPO	Bafna Pharmaceuticals IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB
NII
RII
Employee
Others
Total

Bids Received (Subscription)

Anu Laboratories IPO subscribed 8.43x in total, whereas Bafna Pharmaceuticals IPO subscribed .

	Anu Laboratories IPO	Bafna Pharmaceuticals IPO
QIB (times)	2.84x
NII (times)	26.97x
Big NII (times)
Small NII (times)
RII (times)	9.64x
Employee (times)	1.00x
Other (times)
Total (times)	8.43x

Compare with others

Anu Laboratories IPO	Bafna Pharmaceuticals IPO
Sejal IPO	Archidply IPO
Avon Weighing IPO	First Winner IPO
MCX IPO	Sejal IPO
Bafna Pharmaceuticals IPO	Avon Weighing IPO
Niraj Cement Structurals IPO	MCX IPO
Gokul Refoils IPO	Niraj Cement Structurals IPO
Aishwarya Telecom IPO	Anu Laboratories IPO
Titagarh Wagons IPO	Gokul Refoils IPO
kiri dyes IPO	Aishwarya Telecom IPO
Sita Shree IPO	Titagarh Wagons IPO

Comments

Add a public comment...